COMPARISON OF THE EFFICACY OF 10 DAY-TRIPLE THERAPY-BASED, BISMUTH- CONTAINING QUADRUPLE THERAPY WITH TRIPLE THERAPY FOR THE FIRST LINE THERAPY OF HELICOBACTER PYLORI

被引：0
|
作者：
Moon, B. S. [1 ]
Yi, S. W. [1 ]
Lim, H. C. [1 ]
Lee, Y. C. [2 ]
机构：
[1] Yonsei Univ, Yongin Severance Hosp, Seoul 120749, South Korea
[2] Yonsei Univ, Severance Hosp, Seoul 120749, South Korea
来源：
HELICOBACTER | 2015年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P02.10
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [21] The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori
    Uygun, Ahmet
    Kadayifci, Abdurrahman
    Safali, Mukerrem
    Ilgan, Seyfettin
    Bagci, Sait
    JOURNAL OF DIGESTIVE DISEASES, 2007, 8 (04) : 211 - 215
  • [22] Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori
    Seyyedmajidi, Mohamadreza
    Abbasi, Laleh
    Seyedmajidi, Seyedali
    Hosseini, Seyed Ashkan
    Ahmadi, Anahita
    Hajiebrahimi, Shahin
    Vafaeimanesh, Jamshid
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2019, 10 (02) : 211 - 216
  • [23] Modified quadruple therapy or bismuth-containing quadruple therapy in the first-line treatment of Helicobacter pylori in Turkey
    Yozgat, Ahmet
    Kasapoglu, Benan
    Demirci, Selim
    Sokmen, Fevzi Coskun
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2021, 113 (07) : 490 - 493
  • [24] Moxifloxacin Containing Triple Therapy vs. Moxifloxacin and Bismuth-Containing Quadruple Therapy for First-Line Treatment of Helicobacter pylori (H. pylori) Infection
    Ciccaglione, Antonio Francesco
    Cellini, Luigina
    Grossi, Laurino
    Di Tullio, Ada Maria
    Pagliaro, Mauro
    Tavani, Roberta
    Cocciolillo, Sila
    Marzio, Leonardo
    GASTROENTEROLOGY, 2012, 142 (05) : S482 - S482
  • [25] Efficacy of 7-day bismuth-based quadruple therapy versus 14-day moxifloxacinbased triple therapy for second-line treatment of Helicobacter Pylori infection
    Kim, S.
    Roh, J.
    Park, M.
    Park, S.
    Moon, W.
    Kim, J.
    Jung, K.
    Seol, S.
    HELICOBACTER, 2016, 21 : 142 - 142
  • [26] Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection
    Lim, Ji Hyun
    Lee, Dong Ho
    Lee, Seong Tae
    Kim, Nayoung
    Park, Young Soo
    Shin, Cheol Min
    Song, In Sung
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (46) : 13124 - 13131
  • [27] Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection
    Ji Hyun Lim
    Dong Ho Lee
    Seong Tae Lee
    Nayoung Kim
    Young Soo Park
    Cheol Min Shin
    In Sung Song
    World Journal of Gastroenterology, 2015, (46) : 13124 - 13131
  • [28] A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study
    Ciccaglione, Antonio Francesco
    Cellini, Luigina
    Grossi, Laurino
    Manzoli, Lamberto
    Marzio, Leonardo
    HELICOBACTER, 2015, 20 (05) : 390 - 396
  • [29] Triple therapy-based targeted nanoparticles for the treatment of Helicobacter pylori
    Ramteke, Suman
    Ganesh, N.
    Bhattacharya, S.
    Jain, Narendra K.
    JOURNAL OF DRUG TARGETING, 2008, 16 (09) : 694 - 705
  • [30] Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies
    Ciccaglione, Antonio Francesco
    Tavani, Roberta
    Grossi, Laurino
    Cellini, Luigina
    Manzoli, Lamberto
    Marzio, Leonardo
    HELICOBACTER, 2016, 21 (05) : 375 - 381
12345